Papers
2
Total Citations
3
H-Index
1
About
Dr. Su Hyeong Park is a pioneering hepatopancreatobiliary surgeon whose research focuses on advancing minimally invasive pancreatic surgery, particularly through the comparative evaluation of novel robotic platforms and the optimization of neoadjuvant treatment strategies. His major contributions include the first comparative analysis of Artisential®-assisted versus Da Vinci®-assisted pancreatoduodenectomy, demonstrating that the Artisential® system offers a cost-effective, accessible alternative to established robotic platforms without compromising surgical outcomes. This work, with 2 citations, addresses critical barriers to the widespread adoption of robotic pancreatic surgery. Additionally, Dr. Park reported a landmark case of margin-negative minimally invasive pancreatoduodenectomy following FOLFIRINOX neoadjuvant chemotherapy for invasive intraductal papillary mucinous neoplasm (IPMN) in a young patient, showcasing how preoperative chemotherapy can enable curative resection in initially challenging scenarios. His research has direct implications for expanding patient access to advanced surgical care and improving oncologic outcomes. Dr. Park’s work is notable for bridging the gap between surgical innovation and clinical practicality, making him a key figure in the evolution of minimally invasive pancreatic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2